User menu

A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies.

Bibliographic reference Graux, Carlos ; Sonet, Anne ; Maertens, Johan ; Duyster, Justus ; Greiner, Jochen ; et. al. A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies.. In: Leukemia Research, Vol. 37, no.9, p. 1100-1106 (2013)
Permanent URL http://hdl.handle.net/2078.1/134350